Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Mitsudomi

Showing results (91-100 of 336) with videos related to

Pageof 34
Sort By:
Surgery Today|November 28, 2012
Pulmonary metastasectomy for gastric cancer: a 13-year single-institution experienceYoshihisa Kobayashi, Takayuki Fukui, Seiji Ito, et al.
Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia|November 9, 2010
Serum carcinoembryonic antigen level as a surrogate marker for the evaluation of tumor response to chemotherapy in nonsmall cell lung cancerFutoshi Ishiguro, Takayuki Fukui, Shoichi Mori, et al.
Interactive Cardiovascular and Thoracic Surgery|July 30, 2009
Comparison of methods for placing and managing a silastic drain after pulmonary resectionTakayuki Fukui, Noriaki Sakakura, Rei Kobayashi, et al.
Cancer Science|June 26, 2003
Prognostic models in patients with non-small-cell lung cancer using artificial neural networks in comparison with logistic regressionTaizo Hanai, Yasushi Yatabe, Yusuke Nakayama, et al.
International Journal of Cancer|June 10, 2003
RASSF1A gene inactivation in non-small cell lung cancer and its clinical implicationHideki Endoh, Yasushi Yatabe, Shigeki Shimizu, et al.
Oncology Letters|March 11, 2021
Integrin-linked kinase pathway in heterogeneous pulmonary sarcomatoid carcinomaShigeki Shimizu, Kazuko Sakai, Takaaki Chikugo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 5, 2007
Controversy about small peripheral lung adenocarcinomas: how should we manage them?Takayuki Fukui, Noriaki Sakakura, Shoichi Mori, et al.
Lung Cancer (Amsterdam, Netherlands)|November 9, 2015
MET gene exon 14 deletion created using the CRISPR/Cas9 system enhances cellular growth and sensitivity to a MET inhibitorYosuke Togashi, Hiroshi Mizuuchi, Shuta Tomida, et al.
International Journal of Clinical Oncology|June 20, 2022
Survival benefit of using pemetrexed for EGFR mutation-positive advanced non-small-cell lung cancer in a randomized phase III study comparing gefitinib to cisplatin plus docetaxel (WJTOG3405)Naoki Haratake, Mototsugu Shimokawa, Takashi Seto, et al.
The Annals of Pharmacotherapy|February 10, 2011
The Pharmacogenetic Rescue of Side-Lined Anticancer Drugs to the Front-Line: Gefitinib as a Case ExampleAlain Li-Wan-Po, Peter A Farndon, Susumu Kobayashi, et al.
Pageof 34

Showing results (91-100 of 336) with videos related to

Sort By:
Pageof 34
Surgery Today|November 28, 2012
Pulmonary metastasectomy for gastric cancer: a 13-year single-institution experienceYoshihisa Kobayashi, Takayuki Fukui, Seiji Ito, et al.
Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia|November 9, 2010
Serum carcinoembryonic antigen level as a surrogate marker for the evaluation of tumor response to chemotherapy in nonsmall cell lung cancerFutoshi Ishiguro, Takayuki Fukui, Shoichi Mori, et al.
Interactive Cardiovascular and Thoracic Surgery|July 30, 2009
Comparison of methods for placing and managing a silastic drain after pulmonary resectionTakayuki Fukui, Noriaki Sakakura, Rei Kobayashi, et al.
Cancer Science|June 26, 2003
Prognostic models in patients with non-small-cell lung cancer using artificial neural networks in comparison with logistic regressionTaizo Hanai, Yasushi Yatabe, Yusuke Nakayama, et al.
International Journal of Cancer|June 10, 2003
RASSF1A gene inactivation in non-small cell lung cancer and its clinical implicationHideki Endoh, Yasushi Yatabe, Shigeki Shimizu, et al.
Oncology Letters|March 11, 2021
Integrin-linked kinase pathway in heterogeneous pulmonary sarcomatoid carcinomaShigeki Shimizu, Kazuko Sakai, Takaaki Chikugo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 5, 2007
Controversy about small peripheral lung adenocarcinomas: how should we manage them?Takayuki Fukui, Noriaki Sakakura, Shoichi Mori, et al.
Lung Cancer (Amsterdam, Netherlands)|November 9, 2015
MET gene exon 14 deletion created using the CRISPR/Cas9 system enhances cellular growth and sensitivity to a MET inhibitorYosuke Togashi, Hiroshi Mizuuchi, Shuta Tomida, et al.
International Journal of Clinical Oncology|June 20, 2022
Survival benefit of using pemetrexed for EGFR mutation-positive advanced non-small-cell lung cancer in a randomized phase III study comparing gefitinib to cisplatin plus docetaxel (WJTOG3405)Naoki Haratake, Mototsugu Shimokawa, Takashi Seto, et al.
The Annals of Pharmacotherapy|February 10, 2011
The Pharmacogenetic Rescue of Side-Lined Anticancer Drugs to the Front-Line: Gefitinib as a Case ExampleAlain Li-Wan-Po, Peter A Farndon, Susumu Kobayashi, et al.
Pageof 34